Impact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training.

Hdl Handle:
http://hdl.handle.net/10147/206371
Title:
Impact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training.
Authors:
Long, R; Connolly, S; Sweeney, P
Affiliation:
Mercy University Hospital, Grenville Place, Cork. ronanlong@hotmail.com
Citation:
Ir Med J. 2010 Oct;103(9):281-2.
Journal:
Irish medical journal
Issue Date:
31-Jan-2012
URI:
http://hdl.handle.net/10147/206371
PubMed ID:
21186754
Abstract:
Medical therapy has become first line treatment for Benign Prostatic Hypertrophy (BPH) and in many cases TURP may no longer be required. Proof and quantification of this evolution in practice has been somewhat elusive and provided the principle impetus for this study. This is a retrospective study of BPH management in Republic of Ireland from 1995 to 2008. National treatment databases were sourced for numbers undergoing TURP and pharmacotherapy prescribing data was obtained from individual pharmaceutical companies. A total of 28,240 TURP's were performed nationally between 1995 and 2008. TURP's performed annually, decreased by 1,494 (51%), alpha-blocker prescriptions increased from 8,710 to 302,159 units and the number of urology trainees increased by 10 (60%). Clear association between decreases in TURP's and increases in pharmacotherapy for BPH is demonstrated. Implications on training likely exist and will require proper evaluation in order to maintain future standards in this surgical practice.
Language:
eng
MeSH:
5-alpha Reductase Inhibitors/therapeutic use; Adrenergic alpha-1 Receptor Antagonists/therapeutic use; Drug Utilization/trends; Humans; Ireland; Male; Prostatic Hyperplasia/*drug therapy/surgery; Retrospective Studies; Transurethral Resection of Prostate/*trends/utilization
ISSN:
0332-3102 (Print); 0332-3102 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorLong, Ren_GB
dc.contributor.authorConnolly, Sen_GB
dc.contributor.authorSweeney, Pen_GB
dc.date.accessioned2012-01-31T16:39:37Z-
dc.date.available2012-01-31T16:39:37Z-
dc.date.issued2012-01-31T16:39:37Z-
dc.identifier.citationIr Med J. 2010 Oct;103(9):281-2.en_GB
dc.identifier.issn0332-3102 (Print)en_GB
dc.identifier.issn0332-3102 (Linking)en_GB
dc.identifier.pmid21186754en_GB
dc.identifier.urihttp://hdl.handle.net/10147/206371-
dc.description.abstractMedical therapy has become first line treatment for Benign Prostatic Hypertrophy (BPH) and in many cases TURP may no longer be required. Proof and quantification of this evolution in practice has been somewhat elusive and provided the principle impetus for this study. This is a retrospective study of BPH management in Republic of Ireland from 1995 to 2008. National treatment databases were sourced for numbers undergoing TURP and pharmacotherapy prescribing data was obtained from individual pharmaceutical companies. A total of 28,240 TURP's were performed nationally between 1995 and 2008. TURP's performed annually, decreased by 1,494 (51%), alpha-blocker prescriptions increased from 8,710 to 302,159 units and the number of urology trainees increased by 10 (60%). Clear association between decreases in TURP's and increases in pharmacotherapy for BPH is demonstrated. Implications on training likely exist and will require proper evaluation in order to maintain future standards in this surgical practice.en_GB
dc.language.isoengen_GB
dc.subject.mesh5-alpha Reductase Inhibitors/therapeutic useen_GB
dc.subject.meshAdrenergic alpha-1 Receptor Antagonists/therapeutic useen_GB
dc.subject.meshDrug Utilization/trendsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIrelanden_GB
dc.subject.meshMaleen_GB
dc.subject.meshProstatic Hyperplasia/*drug therapy/surgeryen_GB
dc.subject.meshRetrospective Studiesen_GB
dc.subject.meshTransurethral Resection of Prostate/*trends/utilizationen_GB
dc.titleImpact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training.en_GB
dc.contributor.departmentMercy University Hospital, Grenville Place, Cork. ronanlong@hotmail.comen_GB
dc.identifier.journalIrish medical journalen_GB
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.